Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. (CLRB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLRB · as of Jun 9, 2026
Key Statistics
Explore Cellectar Biosciences, Inc. Data
clrb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 87.5%
The CLRB analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +338.25% upside from the current price of $2.51.
Competitors & Peers
clrb competitorsCLRB
AEON
BOLT
CING
EVGN
IMNNStock Performance
Full HistoryAbout Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc. Cellectar Biosciences is a biopharmaceutical firm engaged in the research, development, and market introduction of therapeutic agents to combat cancer. The company's primary asset is CLR 131 (iopofosi…
what is cellectar biosciences, inc. · clrb stock overview · cellectar biosciences, inc. company profile · who is cellectar biosciences, inc. ceo · clrb NASDAQ · cellectar biosciences, inc. headquarters · cellectar biosciences, inc. business segments
About Stock Overview & Key Data
Cellectar Biosciences, Inc. (CLRB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 10, 2005. As of the latest trading session, CLRB stock price is $2.51, with a market capitalization of $8.0M. The stock has returned -76.43% over the past 12 months and -14.92% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Cellectar Biosciences, Inc. stock is Buy, with an average 12-month price target of $11.00. In fiscal year 2025, Cellectar Biosciences, Inc. reported revenue of — and net income of -$21.8M. For detailed data — including Cellectar Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cellectar Biosciences, Inc. (CLRB) stock price is $2.51. The stock is traded on NASDAQ under the ticker symbol CLRB. The 52-week range is $2.43 – $14.10.